Skip to main content
. 2017 Aug 2;8(39):66087–66097. doi: 10.18632/oncotarget.19798

Figure 3. The impact of RAS expressions on overall survival in CN-AML patients by bioinformatics analysis.

Figure 3

Two independent cohorts of 78 and 162 CN-AML patients were obtained from Gene Expression Omnibus data (http://www.ncbi.nlm.nih.gov/geo/; accession number GSE12417). Survival analysis was performed through the online web tool Genomicscape (http://genomicscape.com/microarray/survival.php). (A) For KRAS in a cohort of 78 CN-AML patients. (B) For KRAS in a cohort of 162 CN-AML patients. (C) For NRAS in a cohort of 78 CN-AML patients. (D) For NRAS in a cohort of 162 CN-AML patients.